The innate immune system has evolved to play an integral role in the normally developing lung and brain. However, in response to oxidative stress, innate immunity, mediated by specific cellular and molecular programs and signaling, contributes to pathology in these same organ systems. Despite opposing drivers of oxidative stress, namely hyperoxia in neonatal lung injury and hypoxia/ischemia in neonatal brain injury, similar pathways-including toll-like receptors, NFκB and MAPK cascades-have been implicated in tissue damage. In this review, we consider recent insights into the innate immune response to oxidative stress in both neonatal and adult models to better understand hyperoxic lung injury and hypoxic-ischemic brain injury across development and aging. These insights support the development of targeted immunotherapeutic strategies to address the challenge of harnessing the innate immune system in oxidative stress diseases of the neonate.
| OXIDATIVE STRESS: INJURY PROVIDES A WINDOW INTO THE INNATE IMMUNE RESPONSE
It could be argued that birth represents the moment in life at which a human being encounters the highest risk of injury secondary to oxidative stress. Throughout gestation, normal development proceeds in an oxygen tension that would kill most adult humans within a matter of minutes. 1 With birth, the environment instantly changes to one rich in oxygen and its associated toxicities. Furthermore, a risk for interruption of normal blood and oxygen delivery occurs with the transition away from placental support for gas exchange. Important observations made during this transition provide insight on oxygen toxicity, the innate immune response to oxidative stress, and how these responses are unique to the perinatal period.
Clinically, two diseases directly related to "oxidative stress" and exclusively encountered in the perinatal period exemplify these lessons-bronchopulmonary dysplasia (BPD) and hypoxic-ischemic encephalopathy (HIE). Bronchopulmonary dysplasia is the most common morbidity complicating preterm birth and affects 10 000-15 000 infants per year in the United States alone. 2 Those born at the earliest gestation ages (<28 weeks) are at the highest risk of developing BPD, and due to increased survival of these babies, the incidence of BPD is increasing. 3 Babies at the highest risk of developing BPD are born in the late cannalicular/early saccular stage of lung development, often resulting in poor gas exchange and hypoxemia. 4 It is clear that supplemental oxygen delivered to the premature lung to overcome this hypoxemia contributes to the pathogenesis of BPD, 5 and simply the cumulative oxygen exposure over the first 2 weeks of life predicts the development of this chronic disease. 6 Hypoxic-ischemic encephalopathy often results from peripartum hypoxic and/or ischemic events and has been estimated to account for one in five neonatal deaths worldwide, leading to 717 000 deaths in 2010. 7 Clinically, encephalopathy is characterized by disturbed neurological function shortly after birth, evidenced by decreased level of consciousness, depressed tone and reflexes, possibility of seizures, and often with impaired respiratory effort. 8 Survivors of moderate-tosevere HIE are at risk for long-term motor, behavioral and cognitive impairments. 9 Whereas hyperoxia contributes to the pathogenesis of BPD in preterm infants, HIE results from decreased oxygen and metabolic substrates as a result of ischemia and is classically defined as occurring in term (>37-week gestation) and near-term infants (36-37-week gestation). Therefore, while preterm infants (<36-week gestation) are certainly at risk for hypoxic brain injury, this review will focus on HIE-related brain injury in term and near-term infants.
Thus, these "oxygen radical diseases" of the neonate period provide a unique opportunity to study a unique aspect of perinatal immunology. 10 The ultimate goal remains understanding how an innate immune response to oxidative stress unique to the perinatal period protects against, and potentially contributes to, these disease states.
Through this effort, we may be able to apply what has been learned in other disease states and develop therapeutic strategies. In this review, we will use clinical and pre-clinical studies of BPD and HIE to demonstrate an emerging body of evidence that support the extraordinary presence of perinatal innate immune response to oxidative stress.
| THE RESPONSE TO OXIDATIVE STRESS VARIES ACROSS DEVELOPMENT AND AGING-LESSONS FROM HYPEROXIC LUNG INJURY
Pulmonary injury induced by breathing high percentages of inspired oxygen was first described nearly 250 years ago. 11 Experiments over the first part of the last century revealed that younger animals were relatively "resistant" to the toxic effects of oxygen when compared to their adult counterparts. This was true for turtles, 12 rats, 13 fruit flies, 14 and cats. 15 In 1957, it was noted that neonatal rats were resistant to oxygen toxicity. 13 This observation was made during studies into relationship between oxygen and retrolental fibroplasia (now known as retinopathy of prematurity). The investigators were attempting to expose the newborn rat to hyperoxia to determine the effect on the immature retinal vessels; however, the studies could not be completed due to the pulmonary toxicity noted in the nursing dams. Exposed to oxygen at the same time, neonatal and adult rats exhibited very different susceptibility to injury. After struggling with this for "several In 1954, Gerschman and colleagues proposed that similar to radiation poisoning, oxygen toxicity resulted from direct injury to tissues from excess generation of oxidizing free radicals. 19 Further work demonstrated that during hyperoxia, oxygen free radicals are produced by the electron transport chain in the mitochondria and by membrane-bound NADPH oxidase. 20 In the adult lung exposed to hyperoxia, injury from increased free radical production manifests as endothelial and alveolar cell destruction, pulmonary edema, and death. 21 In the neonatal lung, arrested alveolar development leads to long-term pulmonary dysfunction. 18, 22 Given the mechanism of injury, interest grew in defining the role of a protective antioxidant response. 23 With these studies, differences in hyperoxia-induced antioxidant enzyme expression were noted between neonatal and adult animals. 16, 24, 25 
| RESPONDING TO HYPEROXIA: WHAT THE TRANSCRIPTIONAL RESPONSE TELLS US ABOUT SIGNALING AND SENSING
For the purposes of this review, we will work backward from the nu- 
| Redox-sensitive transcription factors: different roles at different developmental stages
Multiple redox-sensitive transcription factors have been implicated in the pulmonary response to oxygen including activator protein 1
(AP-1), nuclear factor, erythroid 2-related factor 2 (Nrf2), and nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB). 26, 27 Hyperoxia-induced Nrf2 activity is protective in both neonatal and adult animals. 28, 29 In contrast, previous studies have demonstrated that maturational differences in hyperoxia-induced pulmonary activation of AP1 and NFκB. 30, 31 The transcription factor NFκB is a key component of the innate immune system has been termed the "master regulator of the inflammatory response," and one could hypothesize that targeting its activity in the perinatal lung could be beneficial.
Certainly, inhibiting NFκB activity has been actively pursued as a way to prevent injury associated with inflammation. 
| Signaling
How hyperoxia signals changes in transcription has long been a subject of debate. It is possible that observed transcriptional changes are secondary to programed signaling, or dysregulation of cellular signaling pathways, or a combination of both. The implications are important: if the response is programed, and either injurious or protective, therapies would aim to enhance or attenuate that response. If the signaling is dysregulated, therapies would aim to restore homeostatic cellular signaling mechanisms. The targets that ROS could affect to dysregulate normal cell signaling are nearly infinite, and a discussion here goes beyond the purpose of this review. We will focus instead on redox-sensitive signaling pathways known to affect the response to hyperoxia.
| Developmental differences in hyperoxiainduced pulmonary MAPK signaling
The role of two mitogen-activated protein kinase (MAPK) cascades, extracellular signal-regulated kinase (ERK) 1/2 and c-Jun N-terminal kinase (JNK), have been well studied in pathogenesis of hyperoxiainduced lung injury. 41 The ERK 1/2 MAPK cascade lies upstream of multiple key transcription factors. 42 Following exposure to oxidant stress, ERK signaling is generally considered to be "pro-survival" [43] [44] [45] and occurs in multiple cell types including fibroblasts, smooth muscle, endothelial and epithelial cells in response to hyperoxia. and only occurs in the adult lung with the addition of mechanical ventilation. 65 The effect of ERK blockade on hyperoxia-induced lung injury has been inconsistent, 59 ,60 but appears to benefit the adult. 55 Taken together, we can conclude that hyperoxia-induced ERK activation is developmentally regulated, and conclusions drawn from these and future investigations must be placed in the correct context. 60, 67 potentially through attenuation of TGF-β1 signaling. [68] [69] [70] In direct contrast to this finding in neonatal mice, absence of JNK signaling increases susceptibility to hyperoxia in adults. 71 Of note, TGF-beta1 does not increase in the adult lung exposed to hyperoxia. 72 The results of these studies emphasize that consideration of the developmental stage is critical when choosing therapeutic targets to attenuate lung injury.
| Sensing: TLR, DAMPs, and more
The current paradigm suggests that exposure to hyperoxia results in ROS that overcome antioxidant defenses resulting in cellular dysfunction and death. 11, 26, 73 This proposed mechanism implies that the lung injury is inevitable following exposure to hyperoxia. Another guiding dogma is that hyperoxia is a byproduct of modern medicine never before encountered, thus robbing evolution of the opportunity to orchestrate a well-executed response. Whether gradual changes in atmospheric oxygen, 74 or the "relative hyperoxia" encountered with Charles Janeway hypothesized the presence of innate immune receptors in 1989, 76 and Nobel Prize-winning work uncovered the presence of toll-like receptors. 77 Since that time, our understanding of how these pattern-recognition receptors (PRR) allow our immune system to recognize pathogen-associated molecular patterns (PAMPs) has evolved greatly. 77 It has since been recognized that in damageassociated molecular patterns (DAMPs) also stimulate the innate immune response. 73 DAMPs include a diverse set of ligands including fibronectin, heat-shock proteins, HMGB1, and surfactant proteins A and D that can signal through TLRs. 78 Our understanding of the role of TLR in mediating injury following ischemia-reperfusion is increasing. 79 However, relatively, little is known about how hyperoxia and reactive oxygen species interface with the innate immune response through TLR signaling.
Many DAMPs have been implicated in the pathogenesis of lung
injury following exposure to hyperoxia. Pulmonary fibronectin levels increase in both adult [80] [81] [82] 
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Early studies demonstrated an impaired neonatal response to TLR 1/2, TLR2/6, TLR4, and TLR7 agonists, while the response to a TLR7/8 agonist was fully intact. 99 Interestingly, following birth, the TLR3, TLR7, and TLR9 response rapidly reaches adult levels, whereas the TLR4 response takes longer to develop. [105] [106] [107] [108] Furthermore, the induction of some pro-inflammatory cytokines is at adult levels following TLR8 or TLR9 activation. 106, [109] [110] [111] In fact, neonatal blood dendritic cells respond to TLR7 and TLR9 stimulation at levels equal to or higher than similarly exposed adult cells. 112 Of note, the inves- It is likely that these developmental differences in TLR signaling will dictate age-specific therapeutics to prevent hyperoxia-induced lung injury.
| THE RESPONSE TO OXIDATIVE STRESS VARIES ACROSS DEVELOPMENT AND AGING-LESSONS FROM HYPOXIC/ ISCHEMIC BRAIN INJURY
Injury to the developing brain is a major contributor to morbidity and mortality in preterm and term infants. As with BPD, the pathophysiology of neonatal brain injury is complex and multifactorial. As described above, oxygen exposure contributes to neonatal lung injury.
In contrast, neonatal brain injury is largely due to ischemia and decreased oxygen, with generation of reactive oxygen species linking the pathogenesis of both disease states. In general, the mechanisms leading to ischemic brain injury are believed to be similar in the developing brain and in adults and have been reviewed in depth elsewhere. [116] [117] [118] However, there are some differences, likely owing in part to the emerging role of innate inflammation in shaping synaptic communication and neuronal proliferation.
| The blood-brain barrier and immune access
Historically, the mature central nervous system was considered "immunologically privileged" due to the blood-brain barrier and its prevention of non-specific leakage of molecules and cells from the blood into the brain. In contrast, in the neonatal period, the bloodbrain barrier (BBB) was considered immature and leaky. However, we now know that neither of these paradigms is true. It is now apparent that immune responses from infiltrating leukocytes, cytokines, and chemokines play important roles in both neuroprotection and hypoxic/ischemic damage in both adult and developing brains.
116,119-121
Further, there is now evidence that the tight junctions that are essential for an intact BBB are formed and functional early in embryonic development, 122 possibly as early as E15 in mouse embryos.
123
Despite this, capillaries within the rat cortex do not have an adultlike appearance until postnatal day (PND) [14] [15] [16] [17] [18] [19] [20] [21] 124 suggesting that the structural and molecular organization of the BBB evolves over early development. Interestingly, it has been demonstrated that IgG accumulations following intrastriatal injections of IL-1β or TNF-α are higher in 21-day-old rats compared to 2-hour old pups, implicating that the BBB in neonatal pups may be more resistant to inflammatory stress than in juveniles. 125 However, in response to hypoxia-ischemia (HI), there may be higher permeability to IgG in PND7 rats compared to PND30. 125 Further, in response to experimental stroke, the BBB may be much more permeable in adult rats compared to PND7. 125 Therefore, what was once thought to be a powerful defense against inflammatory response is now considered a key player in pathological inflammatory response, likely in an age-related manner.
As mentioned in previous sections, oxidative stress and inflammation are often interconnected. In the neonatal brain, oxidative stress can initiate an inflammatory response and, in turn, the inflammatory response generates ROS. It has been observed that the developing brain may be further at risk for ROS-mediated injury due to imbalanced brain antioxidant defense mechanisms, high concentrations of unsaturated fatty acids, high rates of oxygen consumption, and low concentrations of antioxidants. 116 Oxidative stress contributes to BBB 
| Innate immunity and signaling in hypoxicischemic brain pathology
The immune response is integral in normal development of the Given the multiple roles of many of these inflammatory mechanisms in developmental regulation, neuroprotection, and injury, studies targeting inflammation should heed attention to timing of inflammatory damage and whether anti-inflammatory agents have adverse affect on brain development.
| CONCLUSIONS
Both BPD and HIE are oxygen radical diseases unique to the perinatal period. An extensive amount of work has been carried out in an attempt to understand the mechanisms linking exposure to oxidative stress and pathogenesis of disease. Through this work, developmentally regulated contributions of the innate immune response have been uncovered. Despite opposing drivers for oxygen radical generation (hyperoxia vs hypoxia), many of these responses are similar in these two pathologies. Further work may ultimately reveal opportunities to either enhance a protective response or attenuate damaging pro-inflammatory signaling unique to the perinatal period.
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